Health Care & Life Sciences » Biotechnology | Vectus Biosystems Ltd.

Vectus Biosystems Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
471.80
2,580.00
4,454.60
516.90
42.00
Total Accounts Receivable
43.30
43.60
96.20
78.30
-
Other Current Assets
7.50
6.40
49.30
59.00
108.00
Total Current Assets
522.60
2,630.00
4,600.20
654.30
150.00
Net Property, Plant & Equipment
195.40
59.60
84.40
66.30
46.00
Total Assets
718.00
2,689.60
4,684.50
720.60
196.00
ST Debt & Current Portion LT Debt
20.80
20.80
5.40
-
912.00
Accounts Payable
276.60
155.60
329.50
73.70
981.00
Income Tax Payable
23.20
16.70
28.10
21.20
-
Other Current Liabilities
269.10
282.80
541.20
497.80
547.00
Total Current Liabilities
589.70
476.00
904.20
592.60
2,440.00
Long-Term Debt
26.20
5.40
-
-
-
Provision for Risks & Charges
46.50
29.20
31.60
11.30
13.00
Total Liabilities
662.50
510.60
935.80
604.00
2,453.00
Common Equity (Total)
55.50
2,179.00
3,748.80
116.60
2,257.00
Total Shareholders' Equity
55.50
2,179.00
3,748.80
116.60
2,257.00
Total Equity
55.50
2,179.00
3,748.80
116.60
2,257.00
Liabilities & Shareholders' Equity
718.00
2,689.60
4,684.50
720.60
196.00

About Vectus Biosystems

View Profile
Address
11 Primrose Avenue
Rosebery New South Wales (NSW) 2018
Australia
Employees -
Website http://www.vectusbiosystems.com.au
Updated 07/08/2019
Vectus Biosystems Ltd. is a drug discovery and development company. It is developing a treatment for fibrosis and high blood pressure, which includes the treatment for diseases in the fibrotic market namely, heart, kidney and liver disease. The company was founded by Karen Duggan on December 12, 2005 and is headquartered in Rosebery, Australia.